These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 19799845

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Lung CD4-CD8- double-negative T cells are prominent producers of IL-17A and IFN-gamma during primary respiratory murine infection with Francisella tularensis live vaccine strain.
    Cowley SC, Meierovics AI, Frelinger JA, Iwakura Y, Elkins KL.
    J Immunol; 2010 May 15; 184(10):5791-801. PubMed ID: 20393138
    [Abstract] [Full Text] [Related]

  • 24. M-Cells Contribute to the Entry of an Oral Vaccine but Are Not Essential for the Subsequent Induction of Protective Immunity against Francisella tularensis.
    Cunningham AL, Guentzel MN, Yu JJ, Hung CY, Forsthuber TG, Navara CS, Yagita H, Williams IR, Klose KE, Eaves-Pyles TD, Arulanandam BP.
    PLoS One; 2016 May 15; 11(4):e0153402. PubMed ID: 27100824
    [Abstract] [Full Text] [Related]

  • 25. Respiratory and oral vaccination improves protection conferred by the live vaccine strain against pneumonic tularemia in the rabbit model.
    Stinson E, Smith LP, Cole KS, Barry EM, Reed DS.
    Pathog Dis; 2016 Oct 15; 74(7):. PubMed ID: 27511964
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Nature of protective immunity to Francisella tularensis.
    Tärnvik A.
    Rev Infect Dis; 1989 Oct 15; 11(3):440-51. PubMed ID: 2665002
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Loss of either CD4+ or CD8+ T cells does not affect the magnitude of protective immunity to an intracellular pathogen, Francisella tularensis strain LVS.
    Yee D, Rhinehart-Jones TR, Elkins KL.
    J Immunol; 1996 Dec 01; 157(11):5042-8. PubMed ID: 8943413
    [Abstract] [Full Text] [Related]

  • 35. [Comparative analysis of parameters of humoral and cell specific immunity in individuals immunized with a live tularemia vaccine].
    Aronova NV, Onoprienko NN, Tsimbalistova MV, Pavlovich NV.
    Zh Mikrobiol Epidemiol Immunobiol; 2014 Dec 01; (5):32-7. PubMed ID: 25536768
    [Abstract] [Full Text] [Related]

  • 36. Tularemia vaccines - an overview.
    McMurry JA, Moise L, Gregory SH, De Groot AS.
    Med Health R I; 2007 Oct 01; 90(10):311-4. PubMed ID: 18019188
    [Abstract] [Full Text] [Related]

  • 37. Expansion of Vgamma9 Vdelta2 T cells is triggered by Francisella tularensis-derived phosphoantigens in tularemia but not after tularemia vaccination.
    Poquet Y, Kroca M, Halary F, Stenmark S, Peyrat MA, Bonneville M, Fournié JJ, Sjöstedt A.
    Infect Immun; 1998 May 01; 66(5):2107-14. PubMed ID: 9573096
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Successful protection against tularemia in C57BL/6 mice is correlated with expansion of Francisella tularensis-specific effector T cells.
    Griffin AJ, Crane DD, Wehrly TD, Bosio CM.
    Clin Vaccine Immunol; 2015 Jan 01; 22(1):119-28. PubMed ID: 25410207
    [Abstract] [Full Text] [Related]

  • 40. [Tularemia vaccine strain is a potential vector].
    Pavlov VM, Mokrievich AN, Noskov AN, Urakov NN.
    Vestn Ross Akad Med Nauk; 1997 Jan 01; (6):30-2. PubMed ID: 9289276
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.